Skip to main content
Move the World.
horse antibodies for covid 19

Lead Image © virgonira / Adobe Stock

With the swirl of excitement around drugmaker Eli Lilly's monoclonal antibody treatment — reported to reduce the severity of COVID-19 — scientists in Costa Rica are looking to create a cheaper, easier-to-manufacture version: using horse antibodies for COVID-19.

Horse blood has a surprisingly long history in human medicine. For over a century, horses, sheep, and other large animals have been inoculated with snake venom, with the resulting robust antibodies purified from their blood and administered as antivenom. 

Much like antibodies against viruses, these equine antibodies bind to venom from snakes, scorpions, spiders, and fish, arresting damage and potentially saving a victim's life.

Using the same method, researchers in Costa Rica are preparing a clinical trial of horse antibodies against COVID-19; if the antibodies prove effective, they could become a relatively cheap weapon to help hold off SARS-CoV-2, especially in low and middle income countries.

And They're Off!

Horse antibodies for COVID-19 are created the same way as humans', from exposure to the virus. Antivenom specialists at the University of Costa Rica's Clodomiro Picado Institute inoculated six donated horses with proteins from the coronavirus.

Three of the horses received only a protein related to SARS-Cov-2's dreaded spike protein, Scientific American reports; the other three got that protein, along with three others. After letting the equine immune system do its thing for a few weeks, the researchers drew their blood and separated out the horse antibodies for COVID-19.

Those antibodies were sent to the National Center for Biodefense and Infectious Disease at George Mason University. "We wanted to determine if the SARS-CoV-2 virus could be neutralized by the horse-produced antibodies," Center executive director Charles Bailey told Scientific American.

"We exposed the antibodies produced in horses, at various dilutions, to the SARS-CoV-2 virus growing on cell culture. The virus was neutralized."

While obviously good news, stopping the virus in a petri dish is, alas, not the same as stopping it in the wild, in humans. Which is why the next step is a clinical trial, where the horse antibodies are going to be tested on 26 patients, beginning in mid-September, Reuters reports. If the results look promising, the project hopes to expand to a larger trial in the nations's hospitals.

A Horse Is the Source, Of Course Of Course

Eli Lilly's much ballyhooed treatment uses what are called monoclonal antibodies; these are manufactured proteins that act like naturally produced antibodies. They're sometimes used to treat cancers and other ailments, but are difficult and expensive to produce. They require a complex process using bacteria that can take two to four weeks, according to the New York Times, and special facilities are needed to create them.

By comparison, horse antibodies for COVID-19 would be easier and cheaper to produce. Monoclonal antibodies are designed to hone in on one specific target, while the horse's antibodies attack many — less precision means easier manufacturing, which means a more affordable treatment. (But that may also mean less efficacy.)

"Here, the horses are the factories — at least for the production part," public health expert Román Macaya told Scientific American. "Then comes the purification part, which is an industrial process, but the Clodomiro Picado Institute already has that infrastructure."

Horse antibodies for COVID-19 would be easier and cheaper to produce than monoclonal antibodies.

Clodomiro Picado Institute COVID-19 lead researcher Alberto Alape Girón estimated a vial of horse antibodies for COVID-19 would cost about $100, Scientific American reports; in comparison, a vial of monoclonal antibodies could be ten times as expensive.

Horses make a ton of antibodies compared to people, as well.

"Just one 10-mL vial has about 80 times the quantity of antibodies you can find in 800 mL of convalescent plasma, which is the plasma donated by someone who has overcome an infection of SARS-CoV-2," Alape-Girón told Scientific American.

Essentially, the well-known processes developed to create antivenoms (and the animals' ubiquity) make horse antibodies for COVID-19 an attractive option.

All of this hinges on the human trials, of course; we're dealing with a superb predator in SARS-CoV-2, and even if they do prove effective, equine antibodies will be a treatment, not a cure. But being able to fight COVID-19 within their own borders would be a source of pride in Costa Rica.

"We are proud to know that this product will save lives until the vaccine reaches the population," Clodomiro Picado Institute project coordinator Alberto Alape told Reuters.

"We do it with our resources, without having to stand in line or compete against other countries, as can be seen with possible vaccines."

Up Next

If you want to understand a problem, talk to the people working on solutions. Join us as we meet the people and explore the ideas on the frontlines of an unprecedented global response.

Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
nanobodies
Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Coronavirus
Patients Report Sudden Hearing Loss From COVID-19
Hearing Loss From COVID-19
Coronavirus
Patients Report Sudden Hearing Loss From COVID-19
Patients are experiencing sudden hearing loss from COVID-19, but if caught early enough, doctors can prevent the problem from becoming permanent.

Patients are experiencing sudden hearing loss from COVID-19, but if caught early enough, doctors can prevent the problem from becoming permanent.

Coronavirus
Gates Foundation Backs a $3 Coronavirus Vaccine
$3 Coronavirus Vaccine
Coronavirus
Gates Foundation Backs a $3 Coronavirus Vaccine
The Gates Foundation is spending $150 million to help with the manufacturing and distribution of a $3 coronavirus vaccine in lower-income nations.

The Gates Foundation is spending $150 million to help with the manufacturing and distribution of a $3 coronavirus vaccine in lower-income nations.

Coronavirus
Moderna’s COVID-19 Vaccine Produces More Antibodies Than Infection
Moderna’s COVID-19 Vaccine
Coronavirus
Moderna’s COVID-19 Vaccine Produces More Antibodies Than Infection
Two shots of Moderna’s COVID-19 vaccine produces more antibodies than a coronavirus infection, according to Phase 1 preliminary data.

Two shots of Moderna’s COVID-19 vaccine produces more antibodies than a coronavirus infection, according to Phase 1 preliminary data.

Public Health
A New Device Is Protecting Healthcare Workers from Airborne Coronavirus
Protecting Healthcare Workers
Public Health
A New Device Is Protecting Healthcare Workers from Airborne Coronavirus
Researchers have developed a system for protecting healthcare workers while they treat coronavirus patients in need of respiratory support.

Researchers have developed a system for protecting healthcare workers while they treat coronavirus patients in need of respiratory support.

Public Health
Contact-Tracing Apps Could Help End Coronavirus Lockdown
Contact-Tracing Apps
Public Health
Contact-Tracing Apps Could Help End Coronavirus Lockdown
A new University of Oxford study found that contact-tracing apps could help bring the coronavirus pandemic to an end without violating citizens' rights.

A new University of Oxford study found that contact-tracing apps could help bring the coronavirus pandemic to an end without violating citizens' rights.

Public Health
Researchers Unveil Low-Cost Coronavirus Ventilator Design
coronavirus ventilator
Public Health
Researchers Unveil Low-Cost Coronavirus Ventilator Design
Researchers have specifically designed a new coronavirus ventilator to address the critical shortage caused by the abundance of COVID-19 patients.

Researchers have specifically designed a new coronavirus ventilator to address the critical shortage caused by the abundance of COVID-19 patients.

Public Health
Private Sector Stepping Up to Combat COVID-19
Private Sector Stepping Up to Combat COVID-19
Public Health
Private Sector Stepping Up to Combat COVID-19
Cosmetics companies and distilleries are making hand sanitizer and the UK asks manufacturers to make ventilators as the private sector responds to the pandemic.

Cosmetics companies and distilleries are making hand sanitizer and the UK asks manufacturers to make ventilators as the private sector responds to the pandemic.